A Study of LN-144 in People With Metastatic Uveal Melanoma

A Study of LN-144 in People With Metastatic Uveal Melanoma
Experimental: Participants with Metastatic Uveal Melanoma

Participants have metastatic uveal melanoma who will undergo surgical excision to generate LN-144

Biological: LN-144

LN-144 is a ready-to-infuse intravenous infusion of autologous TIL obtained from an individual patient’s tumor

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

November 8, 2022Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments